Gangesh Pharma Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 11-12-2024
- Paid Up Capital ₹ 5.66 M
as on 11-12-2024
- Company Age 25 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.65 M
as on 11-12-2024
- Satisfied Charges ₹ 11.65 Cr
as on 11-12-2024
- Revenue 24.18%
(FY 2023)
- Profit -6.49%
(FY 2023)
- Ebitda -20.21%
(FY 2023)
- Net Worth 11.56%
(FY 2023)
- Total Assets 11.80%
(FY 2023)
About Gangesh Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 5.66 M.
The company currently has active open charges totaling ₹5.65 M. The company has closed loans amounting to ₹11.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naresh Goel, Ramesh Goel, and Mayank Goel serve as directors at the Company.
- CIN/LLPIN
U51397DL1999PTC098826
- Company No.
098826
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 1999
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gangesh Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayank Goel  | Director | 30-Apr-2020 | Current |
| Naresh Goel | Director | 12-Mar-1999 | Current |
| Ramesh Goel | Director | 12-Mar-1999 | Current |
Financial Performance and Corporate Structure Insights of Gangesh Pharma.
Gangesh Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.18% increase. The company also saw a slight decrease in profitability, with a 6.49% decrease in profit. The company's net worth Soared by an impressive increase of 11.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gangesh Pharma?
In 2023, Gangesh Pharma had a public holding of 47.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Recova Pharma Expo Private LimitedActive 18 years 9 monthsNaresh Goel and Ramesh Goel are mutual person
- Sentosa Geigy (India) Labs LimitedActive 14 years 10 months
Naresh Goel and Ramesh Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Feb 2023 | ₹1.85 M | Open |
Hdfc Bank Limited Creation Date: 06 Dec 2021 | ₹3.80 M | Open |
Axis Bank Limited Creation Date: 28 Jul 2009 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Gangesh Pharma?
Unlock and access historical data on people associated with Gangesh Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gangesh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gangesh Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
